BJ-2302

BJ-2302 is a potent SRC inhibitor that suppresses TNBC cell invasion, proliferation in vitro, and demonstrates robust anti-tumor and anti-metastatic efficacy in xenograft models, outperforming comparator MMP inhibitors. Its applications include research in cancer metastasis, tumor biology, and preclinical therapeutic development for aggressive cancers like triple-negative breast cancer.